Hermenau; Ronald S. - US Patent Attorneys and Agents

Attorney: Hermenau; Ronald S.

Number of patents: 35
Last date: December 28, 2010

Browse patents
Browse applications

Number	Title	Issue Date
7858785	Aminopyrimidine compounds and methods of use The invention relates to aminopyrimidine compounds useful for treating diseases mediated by polo-like kinase 1 (Plk1). The invention also relates to the therapeutic use of such aminopyrimidine compounds and compositions thereof in treating disease states associated ...	12/28/2010
7799795	Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders Provided herein are compounds of the formula where A1, A2, A3, A4, L, Q, R1, R2, R3, R4, Rx, Ry, Rz, X...	09/21/2010
7531553	Heterocyclic compounds and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods fo...	05/12/2009
7435823	Compounds and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophyl...	10/14/2008
7390820	Substituted quinolinone derivatives and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods fo...	06/24/2008
7320992	Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods fo...	01/22/2008
7307088	Substituted anthranilic amide derivatives and methods of use Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods fo...	12/11/2007
7166586	Sulfonamide lactam inhibitors of FXa and method Sulfonamide lactams of the following formula wherein X, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R7 and ...	01/23/2007
7115645	1,2 diarylbenzimidazoles and their pharmaceutical use Benzimidazoles of general formula I and the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation a...	10/03/2006
7105563	Indolinone derivatives and their use in treating disease-states such as cancer Indolinone derivatives, such as compounds of the formula (I): wherein A, m, n, R1, R2, R3, R5 and R6 are described herein, are discl...	09/12/2006
7053112	Imidazolidinedione analogs useful as anticoagulants and antithrombotics A compound is disclosed, which is useful in treating a mammal having a disease-state characterized by thrombotic activity. The compound is of the following formula: wherein A, B, R1	05/30/2006
6903126	1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the pr...	06/07/2005
6894038	Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases The invention relates to the use of esters of estriol, for example, an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for the treatment of autoimmune diseases, such as multiple sclerosis (MS). ...	05/17/2005
6887865	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	05/03/2005
6864368	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	03/08/2005
6864263	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	03/08/2005
6855714	1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B and Y have the meanings that are indicated in the description and the claims, the use of these compounds for the produ...	02/15/2005
6849739	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	02/01/2005
6846829	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	01/25/2005
6841674	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using the...	01/11/2005
6706720	Heterocyclic dihydropyrimidine compounds Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultr...	03/16/2004
6670473	N-heterocyclic derivatives as NOS inhibitors N-Heterocyclic derivatives of the formula (I): ##STR1## are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors o...	12/30/2003
6596746	Cyclic protein tyrosine kinase inhibitors Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders....	07/22/2003
6555542	Sulfonamide lactam inhibitors of FXa and method Sulfonamide lactams of the following formula ##STR1## wherein X, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R7 and R8 are as described herein, ...	04/29/2003
6544981	Lactam inhibitors of factor Xa and method Lactam inhibitors are provided which have the structure ##STR1## including pharmaceutically acceptable salts thereof and all stereoisomers thereof, and prodrug esters thereof, wherein n is 1 to 5; and and R1, R2, R3, R4	04/08/2003
6525203	Heterocyclic aromatic compounds useful as growth hormone secretagogues Heterocyclic aromatic compounds are provided which are useful in stimulating endogenous production or release of growth hormone and in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength. The heterocycl...	02/25/2003
6469024	Tetrahydroisoquinoline analogs useful as growth hormone secretagogues Tetrahydroisoquinoline analogs are provided which are useful in stimulating endogenous production or release of growth hormone and in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength. The tetrahdrois...	10/22/2002
6271248	Substituted biphenysulfonamide endothelin antagonists Compounds of the formula ##STR1## wherein X, Y, R1, R2, R3, R4 and R5 are as described herein, inhibit the activity of endothelin....	08/07/2001
6268388	Method for preventing or treating erectile dysfunction by administering an endothelin antagonist Prevention or treatment of erectile dysfunction by administration of an endothelin antagonist....	07/31/2001
6239133	Imidazoquinoxaline protein tyrosine kinase inhibitors Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders....	05/29/2001
6143886	Azepinone compounds useful in the inhibition of ACE and NEP Compounds having the following formulae I and II, and pharmaceutically acceptable salts thereof, including dual inhibitors of ACE and NEP and selective ACE inhibitors: ##STR1## and wherein R, R1, R2, R3, R4...	11/07/2000
5939058	Hair styling compositions and method of enhancing the performance of hair fixative resins The present invention provides aqueous low (70 weight percent or less) VOC hair styling compositions. More particuarly, the present invention provides a low VOC hair styling composition containing at least one acrylic hair fixative resin and one or more p...	08/17/1999
5858944	Polycarboxylates for automatic dishwashing detergents Polycarboxylate additives suitable for use in automatic dishwasher detergent compositions are prepared by polymerizing three or more monomers including monoethylenically unsaturated C3 to C6 monocarboxylic acids such as acrylic acid,...	01/12/1999
5854346	Impact modifier combination for aromatic polyesters An improved toughened blend of an aromatic polyester with from 5 to 20 phr of an impact modifier, which impact modifier is a blend of (a) 80 to 85 weight percent of a core/shell impact modifier having a polybutadiene core and at least one shell formed fro...	12/29/1998
5804606	Chelating resins The present invention is concerned with improved chelating resins. More particularly, the present invention is concerned with macroporous, aminoalkylphosphonic or iminodiacetic acid chelating resins having improved stability and capacity in the removal of...	09/08/1998

PatentStorm

Bizarre Patents

PatentStorm News

Attorney: Hermenau; Ronald S.